Vit-Buckle Academy and the Vit-Buckle Society proudly recognize and thank our industry sponsors for their generous support.
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 40 years, we have proudly helped our clients earn more than 45 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.VISIT WWW.ORACLINICAL.COM
Ora is very excited for the opportunity to collaborate and engage with interested vitreoretinal doctors who wish to expand within clinical research. Ora’s network of ophthalmic investigator sites spans the US, Europe, North America, and Asia, but it remains our priority to continuously expand our reach. Our OraNet™ partners are set up to run high-quality clinical trials that make a difference for patients, practices, and the industry overall. As a member of the OraNet™ family, you will have several opportunities each year to participate in exciting and innovative trials across all ophthalmic indications.BECOME AN ORA INVESTIGATOR
Enhancing the future of virtual trials and increasing patient compliance, Ora’s EyeCup™ device leverages smartphone technology to monitor redness of eyes remotely. Patients in dry eye virtual trials can take images at home and submit to a web-based platform through daily uploads and diaries. Photos are reviewed by the investigator in real time.CLICK FOR MORE INFORMATION
As part of Ora’s endpoint program for age-related macular degeneration (AMD), the Ora-VCF™ is a software-based contrast sensitivity test that presents a flickering stimulus on a specific background on a computer display. The test is transitioning from traditional desktop equipment to laptop/tablet devices.